Portfolio company
Telesis Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Telesis Bio develops automated synthetic biology workstations and reagents for researchers to perform rapid, on-site DNA and mRNA synthesis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DNA Script
This company develops benchtop enzymatic DNA synthesis instruments for life science researchers and laboratories to produce synthetic nucleic acids on demand.
Evonetix
The company develops a desktop DNA synthesis platform for researchers in synthetic biology and drug development to produce high-fidelity gene sequences.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
Molecular Assemblies
This company develops enzymatic DNA synthesis technology to provide long, high-quality oligonucleotides for researchers in synthetic biology, therapeutics, diagnostics and data storage.
Elegen
The company manufactures synthetic DNA using cell-free technology for biopharmaceutical and healthcare customers to develop vaccines and genetic medicines.
Trilobio
This company develops modular robotic lab automation systems and software for biologists conducting synthetic biology and life science research.
Twist Bioscience
This company manufactures synthetic DNA on silicon chips for customers in the drug discovery, diagnostics, agriculture, and academic research sectors.
Ribbon Biolabs
The company produces synthetic DNA molecules and assembly kits for biopharmaceutical researchers and synthetic biology organisations.